1h Free Analyst Time
The infantile spasms therapeutics market is forecasted to grow by USD 89.61 mn during 2023-2028, accelerating at a CAGR of 5.41% during the forecast period. The report on the infantile spasms therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in research in neurology and epilepsy, growing demand for infantile spasms therapeutics due to the rising prevalence of infantile spasms and related neurological disorders, and increasing awareness and emphasis on early diagnosis of infantile spasms.
The infantile spasms therapeutics market is segmented as below:
By Route Of Administration
- Parenteral
- Oral
By Drug Class
- Anticonvulsants
- Corticosteroids
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the infantile spasms therapeutics market covers the following areas:
- Infantile spasms therapeutics market sizing
- Infantile spasms therapeutics market forecast
- Infantile spasms therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Route of Administration
7 Market Segmentation by Drug Class
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global infantile spasms therapeutics market: Amneal Pharmaceuticals Inc., Cipla Ltd., Endo International Plc, H Lundbeck AS, Hetero Labs Ltd., Intas Pharmaceuticals Ltd., Jazz Pharmaceuticals Plc, Mallinckrodt Plc, Marinus Pharmaceuticals Inc., MSN Laboratories, Ovid Therapeutics Inc., Sanofi SA, SGPharma Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Anavex Life Sciences Corp., Genix Pharma Pvt. Ltd., Jolly Healthcare, and ORPHELIA Pharma.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing interest in gene therapy.'
According to the report, one of the major drivers for this market is the advancements in research in neurology and epilepsy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amneal Pharmaceuticals Inc.
- Cipla Ltd.
- Endo International Plc
- H Lundbeck AS
- Hetero Labs Ltd.
- Intas Pharmaceuticals Ltd.
- Jazz Pharmaceuticals Plc
- Mallinckrodt Plc
- Marinus Pharmaceuticals Inc.
- MSN Laboratories
- Ovid Therapeutics Inc.
- Sanofi SA
- SGPharma Pvt. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Zydus Lifesciences Ltd.
- Anavex Life Sciences Corp.
- Genix Pharma Pvt. Ltd.
- Jolly Healthcare
- ORPHELIA Pharma
